Web Desc
Stem Cells, Cancer and Metastasis
Organizer(s): Richard J. Gilbertson and Daniel A. Haber
Date: March 06 - 11, 2011
Location: Keystone Resort, Keystone, CO, USA
Sponsored by Astellas Pharma Inc., Celgene Corporation and Takeda Pharmaceutical Company Limited
Summary of Meeting:
Several concepts regarding the origins of cancer and metastasis have converged in recent years. In particular, special interest has focused on the possibility that tissue specific stem cells and cancer cells displaying the properties of these cells play fundamental roles in the malignant process. These concepts have been supported by studies of mouse models in which predictable patterns of tumor spread and access to both primary and metastatic lesions has allowed molecular analyses. With regard to primary tumors, emerging evidence suggests that important cancers, including those in the colon and brain, may arise directly from mutated progenitor cells that display deviant differentiation within 'stem cell-niches'. Tumors appear also to contain stem-like cancer cells that are both necessary and required to propagate the disease. These findings overlap with observations of metastasis that suggest tumor dissemination may be driven by critical changes in tumor cell differentiation, including epithelial to mesenchymal transition (EMT), and the migration of malignant stem cells to 'pre-metastatic niches'. We believe the time is ripe for a joint conference that will bring together scientists and clinicians with interests in stem cell biology, cancer and metastasis. The meeting will provide a forum for exchange of information and insights between these rapidly moving fields. In addition to increasing the sharing of key scientific approaches we believe this conference will galvanize collaborative efforts among disparate research communities to address several key outstanding questions: (i) What is the relationship between normal and malignant tissue stem cells? (ii) What is the relationship between cancer stem cells and the so-called 'metastatic precursor', that is capable of indefinite proliferation at the new metastatic site? (iii) What are the interactions between stromal and stem-like cancer cells in primary and metastatic disease sites? How do these interactions facilitate disease propagation and metastatic spread? (iv) How should we monitor in vivo the biology of stem-like cells in primary tumors and metastasis? (v) What are the optimal approaches to target therapeutically stem-like cancer cells in primary and metastatic disease? By focusing on these questions, we aim to elicit exciting fundamental biological discussions with significant translational application.
Scholarship Deadline: November 4 2010
Discounted Abstract Deadline: November 4 2010
Abstract Deadline: December 9 2010
Discounted Registration Deadline: January 6 2011
We gratefully acknowledge additional support for this conference from:
Astellas Pharma Inc.Celgene CorporationCell Signaling Technology, Inc.CephalonChroma Technology CorporationOncoMed Pharmaceuticals, Inc.Takeda Pharmaceutical Company Limited
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Genentech, Inc.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
The Rockefeller University Press - The Journal of Cell BiologyThe Rockefeller University Press - The Journal of Experimental Medicine
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, March 06 | 3:00PM - 7:30PM
Registration
Room: Longs Peak Foyer


Sunday, March 06 | 6:15PM - 7:15PM
Refreshments
Room: Longs Peak Foyer


Sunday, March 06 | 7:15PM - 8:30PM
Welcome and Keynote Address
Room: Longs/Grays Peak

Speaker 1 of 2
* Richard J. Gilbertson, University of Cambridge, UK

Sunday, March 06 | 7:15PM - 8:30PM
Welcome and Keynote Address
Room: Longs/Grays Peak

Speaker 2 of 2
Robert A. Weinberg, Massachusetts Institute of Technology, USA
Cancer Stem Cells and the Epithelial-Mesenchymal Transition

Monday, March 07 | 7:00AM - 8:00AM
Breakfast
Room: Quandary Peak


Monday, March 07 | 8:00AM - 11:15AM
Stem Cells in Cancer Pathogenesis I: The Controversy of Canc
er Origins

Room: Longs/Grays Peak
Aim: To discuss the controversy surrounding the candidate cell of origin of cancer and the relation to stem cells.
Speaker 1 of 7
* David Lyden, Weill Cornell Medical College, USA

Monday, March 07 | 8:00AM - 11:15AM
Stem Cells in Cancer Pathogenesis I: The Controversy of Canc
er Origins

Room: Longs/Grays Peak
Aim: To discuss the controversy surrounding the candidate cell of origin of cancer and the relation to stem cells.
Speaker 2 of 7
John E. Dick, Princess Margaret Cancer Centre, Canada
Stem Cells in Leukemia: Do They Matter?

Monday, March 07 | 8:00AM - 11:15AM
Stem Cells in Cancer Pathogenesis I: The Controversy of Canc
er Origins

Room: Longs/Grays Peak
Aim: To discuss the controversy surrounding the candidate cell of origin of cancer and the relation to stem cells.
Speaker 3 of 7
Robert J. Wechsler-Reya, Sanford-Burnham Medical Research Institute, USA
Stem Cells Behaving Badly: The Origins of Anaplastic Medulloblastoma

Monday, March 07 | 8:00AM - 11:15AM
Stem Cells in Cancer Pathogenesis I: The Controversy of Canc
er Origins

Room: Longs/Grays Peak
Aim: To discuss the controversy surrounding the candidate cell of origin of cancer and the relation to stem cells.
Speaker 4 of 7
Michael A. Dyer, HHMI/St. Jude Children's Research Hospital, USA
Mature Cells: A Hotbed of Cancer Susceptibility?

Monday, March 07 | 8:00AM - 11:15AM
Stem Cells in Cancer Pathogenesis I: The Controversy of Canc
er Origins

Room: Longs/Grays Peak
Aim: To discuss the controversy surrounding the candidate cell of origin of cancer and the relation to stem cells.
Speaker 5 of 7
Richard J. Gilbertson, University of Cambridge, UK
Do Normal Tissue Stem Cells Drive Cancer Heterogeneity?

Monday, March 07 | 8:00AM - 11:15AM
Stem Cells in Cancer Pathogenesis I: The Controversy of Canc
er Origins

Room: Longs/Grays Peak
Aim: To discuss the controversy surrounding the candidate cell of origin of cancer and the relation to stem cells.
Speaker 6 of 7
Jonathan P. Robson, Institute for Molecular Bioscience, Australia
Short Talk: A Stem-Like Cell as the Cell of Origin for Medulloblastoma

Monday, March 07 | 8:00AM - 11:15AM
Stem Cells in Cancer Pathogenesis I: The Controversy of Canc
er Origins

Room: Longs/Grays Peak
Aim: To discuss the controversy surrounding the candidate cell of origin of cancer and the relation to stem cells.
Speaker 7 of 7
Jungwoo Lee, University of Massachusetts, USA
Short Talk: Implantable Humanized Stem Cell Niches

Monday, March 07 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Monday, March 07 | 11:15AM - 1:00PM
Poster Setup
Room: Quandary Peak


Monday, March 07 | 11:15AM - 11:15AM
On Own for Lunch and Recreation


Monday, March 07 | 1:00PM - 10:00PM
Poster Viewing
Room: Quandary Peak


Monday, March 07 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Monday, March 07 | 5:00PM - 7:00PM
Stem Cells in Cancer Pathogenesis II: Niches and the Metasta
tic Cascade

Room: Longs/Grays Peak
Aim: To discuss the connection between stem cells, niches and metastases.
Speaker 1 of 5
* Robert J. Wechsler-Reya, Sanford-Burnham Medical Research Institute, USA

Monday, March 07 | 5:00PM - 7:00PM
Stem Cells in Cancer Pathogenesis II: Niches and the Metasta
tic Cascade

Room: Longs/Grays Peak
Aim: To discuss the connection between stem cells, niches and metastases.
Speaker 2 of 5
Elaine V. Fuchs, Rockefeller University, USA
Stem Cells and Cancer in the Skin

Monday, March 07 | 5:00PM - 7:00PM
Stem Cells in Cancer Pathogenesis II: Niches and the Metasta
tic Cascade

Room: Longs/Grays Peak
Aim: To discuss the connection between stem cells, niches and metastases.
Speaker 3 of 5
Dorothy A. Sipkins, University of Chicago, USA
The Leukemic Stem Cell Niche

Monday, March 07 | 5:00PM - 7:00PM
Stem Cells in Cancer Pathogenesis II: Niches and the Metasta
tic Cascade

Room: Longs/Grays Peak
Aim: To discuss the connection between stem cells, niches and metastases.
Speaker 4 of 5
David Lyden, Weill Cornell Medical College, USA
Priming the Soil: The Pre-Metastatic Niche

Monday, March 07 | 5:00PM - 7:00PM
Stem Cells in Cancer Pathogenesis II: Niches and the Metasta
tic Cascade

Room: Longs/Grays Peak
Aim: To discuss the connection between stem cells, niches and metastases.
Speaker 5 of 5
Jonathan Chou, University of California, San Francisco, USA
Short Talk: GATA3 Suppresses Metastasis and Induces MicroRNAs that Regulate the Tumor Microenvironment

Monday, March 07 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Quandary Peak


Monday, March 07 | 7:30PM - 10:00PM
Poster Session 1
Room: Quandary Peak


Tuesday, March 08 | 7:00AM - 8:00AM
Breakfast
Room: Quandary Peak


Tuesday, March 08 | 8:00AM - 11:15AM
Genomic Analyses: Reading the Genome in Cancer Stem Cells an
d Metastatic Precursors

Room: Longs/Grays Peak
Aim: To highlight how high-end genomic technologies are being used to inform regarding the deregulation of stem cells in cancer.
Speaker 1 of 7
* Frederic J. de Sauvage, Genentech, Inc., USA

Tuesday, March 08 | 8:00AM - 11:15AM
Genomic Analyses: Reading the Genome in Cancer Stem Cells an
d Metastatic Precursors

Room: Longs/Grays Peak
Aim: To highlight how high-end genomic technologies are being used to inform regarding the deregulation of stem cells in cancer.
Speaker 2 of 7
Charles G. Mullighan, St. Jude Children's Research Hospital, USA
Unmasking the Origins of Leukemia with Genomics

Tuesday, March 08 | 8:00AM - 11:15AM
Genomic Analyses: Reading the Genome in Cancer Stem Cells an
d Metastatic Precursors

Room: Longs/Grays Peak
Aim: To highlight how high-end genomic technologies are being used to inform regarding the deregulation of stem cells in cancer.
Speaker 3 of 7
Robert H. Blelloch, University of California, San Francisco, USA
MicroRNA Regulation of Stem Cells and Cancer

Tuesday, March 08 | 8:00AM - 11:15AM
Genomic Analyses: Reading the Genome in Cancer Stem Cells an
d Metastatic Precursors

Room: Longs/Grays Peak
Aim: To highlight how high-end genomic technologies are being used to inform regarding the deregulation of stem cells in cancer.
Speaker 4 of 7
Joan Massagué, Memorial Sloan Kettering Cancer Center, USA
Cancer Stem Cell Viability in the Metastatic Niche

Tuesday, March 08 | 8:00AM - 11:15AM
Genomic Analyses: Reading the Genome in Cancer Stem Cells an
d Metastatic Precursors

Room: Longs/Grays Peak
Aim: To highlight how high-end genomic technologies are being used to inform regarding the deregulation of stem cells in cancer.
Speaker 5 of 7
Sridhar Ramaswamy, Google Ventures, USA
Spontaneous Cancer Cell Quiescence

Tuesday, March 08 | 8:00AM - 11:15AM
Genomic Analyses: Reading the Genome in Cancer Stem Cells an
d Metastatic Precursors

Room: Longs/Grays Peak
Aim: To highlight how high-end genomic technologies are being used to inform regarding the deregulation of stem cells in cancer.
Speaker 6 of 7
Nicolo Riggi, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland
Short Talk: EWS-FLI-1 Modulates miRNA145 and SOX2 Expression to Initiate Mesenchymal Stem Cell Reprogramming Toward Ewing Sarcoma Cancer Stem Cells

Tuesday, March 08 | 8:00AM - 11:15AM
Genomic Analyses: Reading the Genome in Cancer Stem Cells an
d Metastatic Precursors

Room: Longs/Grays Peak
Aim: To highlight how high-end genomic technologies are being used to inform regarding the deregulation of stem cells in cancer.
Speaker 7 of 7
Fabio Petrocca, Boston University School of Medicine, USA
Short Talk: A Genome-Wide siRNA Screen Identifies Selective Inhibitors of Triple-Negative Breast Tumor-Initiating Cells

Tuesday, March 08 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Tuesday, March 08 | 11:15AM - 1:00PM
Poster Setup
Room: Quandary Peak


Tuesday, March 08 | 11:15AM - 11:15AM
On Own for Lunch and Recreation


Tuesday, March 08 | 1:00PM - 10:00PM
Poster Viewing
Room: Quandary Peak


Tuesday, March 08 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Tuesday, March 08 | 5:00PM - 7:00PM
Breast Cancer
Room: Longs/Grays Peak

Speaker 1 of 5
* Sridhar Ramaswamy, Google Ventures, USA

Tuesday, March 08 | 5:00PM - 7:00PM
Breast Cancer
Room: Longs/Grays Peak

Speaker 2 of 5
Jane E. Visvader, Walter and Eliza Hall Institute of Medical Research, Australia
The Mammary Epithelial Hierarchy and its Implications for Identifying Cells of Origin of Breast Cancer

Tuesday, March 08 | 5:00PM - 7:00PM
Breast Cancer
Room: Longs/Grays Peak

Speaker 3 of 5
Rama Khokha, Ontario Cancer Institute, Canada
Regulation of the Mammary Stem Cell Niche

Tuesday, March 08 | 5:00PM - 7:00PM
Breast Cancer
Room: Longs/Grays Peak

Speaker 4 of 5
Charlotte Kuperwasser, Tufts University School of Medicine, New England, USA
Genetic and Epigenetic Plasticity of Stem Cells in Breast Cancer

Tuesday, March 08 | 5:00PM - 7:00PM
Breast Cancer
Room: Longs/Grays Peak

Speaker 5 of 5
Casey A. Frankenberger, University of Chicago, USA
Short Talk: A Let-7 Signaling Pathway Targets Metastatic Genes Enriched in Tumor Initiating Cells

Tuesday, March 08 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Quandary Peak


Tuesday, March 08 | 7:30PM - 10:00PM
Poster Session 2
Room: Quandary Peak


Wednesday, March 09 | 7:00AM - 8:00AM
Breakfast
Room: Quandary Peak


Wednesday, March 09 | 8:00AM - 11:00AM
Cancer Stem Cells, Metastasis and Cancer Therapy
Room: Longs/Grays Peak
Aim: To discuss current and ongoing efforts to develop new therapies against cancer stem cells and metastatic disease.

Speaker 1 of 6
* Charlotte Kuperwasser, Tufts University School of Medicine, New England, USA

Wednesday, March 09 | 8:00AM - 11:00AM
Cancer Stem Cells, Metastasis and Cancer Therapy
Room: Longs/Grays Peak
Aim: To discuss current and ongoing efforts to develop new therapies against cancer stem cells and metastatic disease.

Speaker 2 of 6
Max S. Wicha, University of Michigan, USA
Therapeutic Implications of Stem Cells in Breast Cancer

Wednesday, March 09 | 8:00AM - 11:00AM
Cancer Stem Cells, Metastasis and Cancer Therapy
Room: Longs/Grays Peak
Aim: To discuss current and ongoing efforts to develop new therapies against cancer stem cells and metastatic disease.

Speaker 3 of 6
Margaret A. Read, Infinity Pharmaceuticals, Inc., USA
Rationale for Smo Inhibition as Therapeutic Intervention in Minimal Residual Disease

Wednesday, March 09 | 8:00AM - 11:00AM
Cancer Stem Cells, Metastasis and Cancer Therapy
Room: Longs/Grays Peak
Aim: To discuss current and ongoing efforts to develop new therapies against cancer stem cells and metastatic disease.

Speaker 4 of 6
Frederic J. de Sauvage, Genentech, Inc., USA
Development of Hedgehog Pathway Inhibitors for the Treatment of Cancer

Wednesday, March 09 | 8:00AM - 11:00AM
Cancer Stem Cells, Metastasis and Cancer Therapy
Room: Longs/Grays Peak
Aim: To discuss current and ongoing efforts to develop new therapies against cancer stem cells and metastatic disease.

Speaker 5 of 6
Richard O. Hynes, Massachusetts Institute of Technology, USA
Extracellular Matrix Effects in Cancer Progression

Wednesday, March 09 | 8:00AM - 11:00AM
Cancer Stem Cells, Metastasis and Cancer Therapy
Room: Longs/Grays Peak
Aim: To discuss current and ongoing efforts to develop new therapies against cancer stem cells and metastatic disease.

Speaker 6 of 6
Johannes Tsung-han Yeh, Harvard Medical School, USA
Short Talk: Drugging the Undruggable: Direct Targeting of beta-catenin in Cancer Stem Cells by Novel Designed Stapled Peptides

Wednesday, March 09 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Wednesday, March 09 | 11:00AM - 1:00PM
Poster Setup
Room: Quandary Peak


Wednesday, March 09 | 11:00AM - 11:00AM
On Own for Lunch and Recreation


Wednesday, March 09 | 1:00PM - 10:00PM
Poster Viewing
Room: Quandary Peak


Wednesday, March 09 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Wednesday, March 09 | 5:00PM - 7:00PM
Imaging and Tracking Cancer Stem Cells and Metastatic Precur
sors

Room: Longs/Grays Peak
Aim: To bring highlight technological advances in stem cell tracking, isolation and imaging.

Speaker 1 of 5
* Richard O. Hynes, Massachusetts Institute of Technology, USA

Wednesday, March 09 | 5:00PM - 7:00PM
Imaging and Tracking Cancer Stem Cells and Metastatic Precur
sors

Room: Longs/Grays Peak
Aim: To bring highlight technological advances in stem cell tracking, isolation and imaging.

Speaker 2 of 5
Peter Kuhn, The Scripps Research Institute, USA
High Definition Circulating Tumor Cells in Carcinoma Patients

Wednesday, March 09 | 5:00PM - 7:00PM
Imaging and Tracking Cancer Stem Cells and Metastatic Precur
sors

Room: Longs/Grays Peak
Aim: To bring highlight technological advances in stem cell tracking, isolation and imaging.

Speaker 3 of 5
Daniel A. Haber, Massachusetts General Hospital, USA
Molecular Characterization of Circulating Tumor Cells

Wednesday, March 09 | 5:00PM - 7:00PM
Imaging and Tracking Cancer Stem Cells and Metastatic Precur
sors

Room: Longs/Grays Peak
Aim: To bring highlight technological advances in stem cell tracking, isolation and imaging.

Speaker 4 of 5
Michael R.H. White, University of Manchester, UK
Systems Analysis in Single Cells

Wednesday, March 09 | 5:00PM - 7:00PM
Imaging and Tracking Cancer Stem Cells and Metastatic Precur
sors

Room: Longs/Grays Peak
Aim: To bring highlight technological advances in stem cell tracking, isolation and imaging.

Speaker 5 of 5
Irène Baccelli, DKFZ (Deutsches Krebsforschungszentrum), Germany
Short Talk: Towards the Functional Analysis of Human Disseminating Tumor Cells (DgTCs)

Wednesday, March 09 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Quandary Peak


Wednesday, March 09 | 7:30PM - 10:00PM
Poster Session 3
Room: Quandary Peak


Thursday, March 10 | 7:00AM - 8:00AM
Breakfast
Room: Quandary Peak


Thursday, March 10 | 8:00AM - 11:15AM
Epithelial Cancers and Stem Cells
Room: Longs/Grays Peak

Speaker 1 of 7
* Michael A. Dyer, HHMI/St. Jude Children's Research Hospital, USA

Thursday, March 10 | 8:00AM - 11:15AM
Epithelial Cancers and Stem Cells
Room: Longs/Grays Peak

Speaker 2 of 7
Marc van de Wetering, Netherlands Institute for Developmental Biology, Netherlands
Wnt Signaling, Lgr5 Stem Cells and Cancer

Thursday, March 10 | 8:00AM - 11:15AM
Epithelial Cancers and Stem Cells
Room: Longs/Grays Peak

Speaker 3 of 7
Joan S. Brugge, Harvard Medical School, USA
Genes that Regulate Migration and Invasion

Thursday, March 10 | 8:00AM - 11:15AM
Epithelial Cancers and Stem Cells
Room: Longs/Grays Peak

Speaker 4 of 7
Carla F. Kim, Boston Children's Hospital, USA
Stem Cells in Normal Lung and Lung Cancer

Thursday, March 10 | 8:00AM - 11:15AM
Epithelial Cancers and Stem Cells
Room: Longs/Grays Peak

Speaker 5 of 7
Courtney W. Houchen, University of Oklahoma Health Sciences Centers, USA
Pancreatic Cancer Stem Cell Marker DCAMKL-1 Regulates Epithelial-Mesenchymal Transition in Human Pancreatic Cells through a miR-200a-Dependent Mechanism

Thursday, March 10 | 8:00AM - 11:15AM
Epithelial Cancers and Stem Cells
Room: Longs/Grays Peak

Speaker 6 of 7
JoAnne M. Montalbano, University of Virginia, USA
Short Talk: The Polarity Protein Par3 Acts as a Tumor Growth and Invasion Suppressor, through Stat3-Dependent Mechanisms

Thursday, March 10 | 8:00AM - 11:15AM
Epithelial Cancers and Stem Cells
Room: Longs/Grays Peak

Speaker 7 of 7
Andrew D. Rhim, University of Michigan Medical School, USA
Short Talk: Genetic Lineage Labeling Identifies New Populations of Circulating Tumor Cells in a Mouse Model of Spontaneous Pancreatic Ductal Adenocarcinoma (PDAC)

Thursday, March 10 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Thursday, March 10 | 11:15AM - 11:15AM
On Own for Lunch and Recreation


Thursday, March 10 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Thursday, March 10 | 5:00PM - 5:45PM
Closing Keynote Address
Room: Longs/Grays Peak

Speaker 1 of 2
* Daniel A. Haber, Massachusetts General Hospital, USA

Thursday, March 10 | 5:00PM - 5:45PM
Closing Keynote Address
Room: Longs/Grays Peak

Speaker 2 of 2
Sean J. Morrison, University of Texas Southwestern Medical Center, USA
Stem Cells and Cancer: Where Are We Now?

Thursday, March 10 | 5:45PM - 7:00PM
Roundtable: Cancer Stem Cells in Metastasis: Insights and Co
ntroversies
Room: Longs/Grays Peak

Speaker 1 of 5
* Daniel A. Haber, Massachusetts General Hospital, USA

Thursday, March 10 | 5:45PM - 7:00PM
Roundtable: Cancer Stem Cells in Metastasis: Insights and Co
ntroversies
Room: Longs/Grays Peak

Speaker 2 of 5
* Richard J. Gilbertson, University of Cambridge, UK

Thursday, March 10 | 5:45PM - 7:00PM
Roundtable: Cancer Stem Cells in Metastasis: Insights and Co
ntroversies
Room: Longs/Grays Peak

Speaker 3 of 5
Sean J. Morrison, University of Texas Southwestern Medical Center, USA

Thursday, March 10 | 5:45PM - 7:00PM
Roundtable: Cancer Stem Cells in Metastasis: Insights and Co
ntroversies
Room: Longs/Grays Peak

Speaker 4 of 5
Robert A. Weinberg, Massachusetts Institute of Technology, USA

Thursday, March 10 | 5:45PM - 7:00PM
Roundtable: Cancer Stem Cells in Metastasis: Insights and Co
ntroversies
Room: Longs/Grays Peak

Speaker 5 of 5
Marc van de Wetering, Netherlands Institute for Developmental Biology, Netherlands

Thursday, March 10 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Quandary Peak


Thursday, March 10 | 8:00PM - 11:00PM
Entertainment
Room: Quandary Peak


Thursday, March 10 | 8:00PM - 11:00PM
Cash Bar
Room: Quandary Peak


Friday, March 11 | 10:25AM - 10:25AM
Departure


*Session Chair.